SBT-272 Offers Mitochondrial Protection in ALS

From October 6-7, 2021, researchers and stakeholders descended upon the virtual Northeast Amyotrophic Lateral Sclerosis Meeting to discuss new trends, research, and therapies within the field. According to ALS News…

Continue Reading SBT-272 Offers Mitochondrial Protection in ALS

Dosing Complete in ANVS401 Trial for AD, PD

  In mid-August 2021, Parkinson's News Today reported that dosing was complete in a Phase 2a clinical trial. During the trial, researchers were evaluated ANVS401, an investigational compound for patients…

Continue Reading Dosing Complete in ANVS401 Trial for AD, PD

Enrollment Complete in RT001 Trial for PSP

  In a recent news release, biopharmaceutical company Retrotope shared that enrollment was complete in its Phase 2 clinical trial. During the trial, researchers will evaluate RT001, a first-in-class oral…

Continue Reading Enrollment Complete in RT001 Trial for PSP

Methamphetamine Use Increases PD Risk

It's no secret that illicit substance use, or substance use disorders, can cause a variety of health effects, including increased risks for certain diseases. As Parkinson's News Today recently reported,…

Continue Reading Methamphetamine Use Increases PD Risk